ChemBioChem · 2007 · 93 citations · 20 references
Life SciencesMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologyMolecular PharmacologyDegradation ProductsEnzymatic Cleavage StrategiesEnzyme InhibitionProtein DegradationProteolytic EnzymesProteolytic ProcessingEnzyme ChimerasProtease-mediated Protein DegradationProteasome-mediated DegradationReceptor DegradationTargeted Protein Degradation
License to degrade. A chimeric small molecule or PROTAC (PROteolysis TArgeting Chimera) based on the chemopreventive natural product apigenin was developed (see scheme). The molecule was shown to target the aryl hydrocarbon receptor (AHR) for degradation by the proteasome.
20
Kathleen M. Sakamoto, Kyung B. Kim, Akiko Kumagai et al. · Proceedings of the National Academy of Sciences · 2001 · 2.5K citations · Full text
Nikos A. Davarinos, Richard S. Pollenz · Journal of Biological Chemistry · 1999 · 293 citations · Full text